OINDPnews


Proveris Scientific

People

Savara acquires rights to inhaled antibiotic, appoints new strategic advisor, and provides update on Molgradex development

Savara has acquired rights to an amikacin/fosfomycin inhalation solution that was being developed by Cardeas Pharma for the treatment of ventilator associated pneumonia and has appointed former Cardeas Pharma CEO A. Bruce Montgomery as a strategic advisor, the company said. The company also announced a public offering of common stock, with shares priced at $11.50 … [Read more...] about Savara acquires rights to inhaled antibiotic, appoints new strategic advisor, and provides update on Molgradex development

Impel NeuroPharma names Lynn Gold Senior VP of Regulatory Affairs

Intranasal drug developer Impel NeuroPharma has hired Lynn C. Gold as Senior VP of Regulatory Affairs, the company said. Gold was most recently VP of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services and had previously served as VP of Research and Process Development at Sonus Pharmaceuticals. In 2017, Impel announced that it had signed service … [Read more...] about Impel NeuroPharma names Lynn Gold Senior VP of Regulatory Affairs

Per Bäckman joins Emmace Consulting

Former Mylan Senior Director of Inhalation Biopharmaceutics Per Bäckman has joined Emmace Consulting as Senior Inhalation Consultant, the company has announced. Bäckman also previously held various positions at AstraZeneca, including as Principal Scientist in Inhalation Biopharmaceutics, and at Novo Nordisk. Emmace Consulting CEO Mårten Svensson said, "Per Bäckman … [Read more...] about Per Bäckman joins Emmace Consulting

Galecto Biotech names Richard Marshall as Chief Medical Officer

Galecto Biotech, which is developing an inhaled galectin-3 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF), has hired former GSK VP and Head of the Fibrosis & Lung Injury Discovery Performance Unit Richard Marshall as its Chief Medical Officer, the company said. Marshall held a number of positions in respiratory drug development at GSK over 15 … [Read more...] about Galecto Biotech names Richard Marshall as Chief Medical Officer

Liquidia Technologies appoints Jeri Thomas Senior VP, Commercial

Liquidia Technologies has named Jeri Thomas as its new Senior VP Commercial, responsible initially for commercial plans for the company's LIQ861 treprostinil DPI, which is currently in Phase 3 development for the treatment of pulmonary arterial hypertension (PAH). According to Liquidia, Thomas was most recently Senior VP, Strategic Group Planning at healthcare … [Read more...] about Liquidia Technologies appoints Jeri Thomas Senior VP, Commercial

Pneuma Respiratory appoints Steven Kesten as President and Chief Medical Officer

Pneuma Respiratory, which introduced a digital soft mist inhaler in November 2017, has announced the appointment of former Boehringer Ingelheim VP of Respiratory Products Steven Kesten as its new President and Chief Medical Officer. Since leaving Boehringer Ingelheim in 2010, Kesten has held VP and Chief Medical Officer positions at Uptake Medical and Cytori … [Read more...] about Pneuma Respiratory appoints Steven Kesten as President and Chief Medical Officer

Copley Scientific appoints Richard Postlethwaite as Chief Operating Officer

Copley Scientific has announced the appointment of an experienced lean manufacturing consultant, Richard Postlethwaite, as Chief Operating Officer. Postlethwaite was most recently Senior Operations Manager of Walgreens Boots Alliance and previously held a number of positions at Reckitt Benckiser and Boots. The company, which recently completed an expansion of its … [Read more...] about Copley Scientific appoints Richard Postlethwaite as Chief Operating Officer